Biological pacemakers as a therapy for cardiac arrhythmias

Current Opinion in Cardiology

Volumn 23, Issue 1, 2008, Pages 46-54

  Marbán, Eduardo ^a,b   Cho, Hee Cheol ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Arrhythmia; Biological pacemakers; Gene and cell therapy

Indexed keywords

CELL FUSION; EMBRYONIC STEM CELL; GENE REPRESSION; GENE TRANSFER; HEART ARRHYTHMIA; HEART PACING; HEART RHYTHM; PACEMAKER; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION;

ADULT STEM CELLS; ARRHYTHMIAS, CARDIAC; BIOLOGICAL CLOCKS; CELL FUSION; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; EMBRYONIC STEM CELLS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 40349092932     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3282f30416     Document Type: Review

References (67)

1. Brooks CM, Lu H. The sinoatrial pacemaker of the heart. Springfield: Charles C. Thomas; 1972.
2. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics: 2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85-e151.
3. Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990; 82:1106-1116.
4. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324:781-788.
5. Siebels J, Cappato R, Ruppel R, et al. Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. Am J Cardiol 1993; 72:109F-113F.
6. Waldo AL, Camm AJ, deRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996; 348:7-12.
7. Richardson AW, Josephson ME. Ablation of ventricular tachycardia in the setting of coronary artery disease. Curr Cardiol Rep 1999; 1:157-164.
8. Falk RH. Atrial fibrillation. N Engl J Med 2001; 344:1067-1078.
9. Kusumoto FM, Goldschlager N. Cardiac pacing. N Engl J Med 1996; 334:89-97.
10. Bernstein AD, Parsonnet V. Survey of cardiac pacing and implanted defibrillator practice patterns in the United States in 1997. Pacing Clin Electrophysiol 2001; 24:842-855.
11. Kubo Y, Baldwin TJ, Jan YN, Jan LY. Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature 1993; 362:127-133.
12. Tinker A, Jan YN, Jan LY. Regions responsible for the assembly of inwardly rectifying potassium channels. Cell 1996; 87:857-868.
13. Miake J, Marban E, Nuss HB. Biological pacemaker created by gene transfer. Nature 2002; 419:132-133.
14. Irisawa H, Brown HF, Giles W. Cardiac pacemaking in the sinoatrial node. Physiol Rev 1993; 73:197-227.
15. Brown HF, McNaughton PA, Noble D, Noble SJ. Adrenergic control of cardian pacemaker currents. Philos Trans R Soc Lond B Biol Sci 1975; 270:527-537.
16. Hoffman LM, Carpenter MK. Characterization and culture of human embryonic stem cells. Nat Biotechnol 2005; 23:699-708.
17. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002; 91:501-508.
18. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108:407-414.
19. He JQ, Ma Y, Lee Y, et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003; 93:32-39.
20. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003; 107:2733-2740.
21. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22:1282-1289.
22. Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005; 111:11-20.
23. Barr L, Dewey MM, Berger W. Propagation of action potentials and the structure of the nexus in cardiac muscle. J Gen Physiol 1965; 48:797-823.
24. Loewenstein WR. Junctional intercellular communication: the cell-to-cell membrane channel. Physiol Rev 1981; 61:829-913.
25. Jalife J, Sicouri S, Delmar M, Michaels DC. Electrical uncoupling and impulse propagation in isolated sheep Purkinje fibers. Am J Physiol 1989; 257:H179-H189.
26. Sperelakis N. An electric field mechanism for transmission of excitation between myocardial cells. Circ Res 2002; 91:985-987.
27. Lakatta EG, Maltsev VA, Bogdanov KY, et al. Cyclic variation of intracellular calcium: a critical factor for cardiac pacemaker cell dominance. Circ Res 2003; 92:e45-e50.
28. Robinson RB, Siegelbaum SA. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu Rev Physiol 2003; 65:453-480.
29. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776.
30. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003; 100:12313-12318.
31. Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004; 279:11384-11391.
32. Martin CM, Meeson AP, Robertson SM, et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 2004; 265:262-275.
33. Pfister O, Mouquet F, Jain M, et al. CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005; 97:52-61.
34. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95:911-921.
35. Anversa P, Kajstura J, Leri A, Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 2006; 113:1451-1463.
36. Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007; 115:896-908. This study described a method for isolation and expansion of human adult cardiac stem cells from a routine endomyocardial biopsy. These stem cells could differentiate into cardiomyocytes upon co-culture with rat myocytes and improved cardiac function when injected into mouse infarct model.
37. Cho HC, Smith R, Abraham M, et al. Electrophysiology of human and porcine adult cardiac stem cells isolated from endomyocardial biopsies. Heart Rhythm 2005; 2:S45.
38. Smith R, Barile L, Cho HC, et al. Unique phenotype of cardiospheres derived from human endomyocardial biopsies. Circulation 2005; 112:II-51.
39. Robertson JA. Human embryonic stem cell research: ethical and legal issues. Nat Rev Genet 2001; 2:74-78.
40. Gerecht-Nir S, Itskovitz-Eldor J. Cell therapy using human embryonic stem cells. Transpl Immunol 2004; 12:203-209.
41. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001; 19:193-204.
42. DiFrancesco D. The pacemaker current (I(f)) plays an important role in regulating SA node pacemaker activity. Cardiovasc Res 1995; 30:307-308.
43. Santoro B, Tibbs GR. The HCN gene family: molecular basis of the hyperpolarization-activated pacemaker channels. Ann N Y Acad Sci 1999; 868:741-764.
44. Ulens C, Tytgat J. Functional heteromerization of HCN1 and HCN2 pacemaker channels. J Biol Chem 2001; 276:6069-6072.
45. Brewster AL, Bernard JA, Gall CM, Baram TZ. Formation of heteromeric hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in the hippocampus is regulated by developmental seizures. Neurobiol Dis 2005; 19:200-207.
46. Cerbai E, Pino R, Porciatti F, et al. Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes from human failing heart. Circulation 1997; 95:568-571.
47. Hoppe UC, Jansen E, Sudkamp M, Beuckelmann DJ. Hyperpolarization- activated inward current in ventricular myocytes from normal and failing human hearts. Circulation 1998; 97:55-65.
48. Brown HF, Kimura J, Noble D, et al. The ionic currents underlying pacemaker activity in rabbit sino-atrial node: experimental results and computer simulations. Proc R Soc Lond B Biol Sci 1984; 222:329-347.
49. Kashiwakura Y, Cho HC, Barth AS, et al. Gene transfer of a synthetic pacemaker channel into the heart: a novel strategy for biological pacing. Circulation 2006; 114:1682-1686. Combination of three mutations in the S4 region and one mutation in the pore region of human Kv1.4 channel converted the wild-type channel to a synthetic pacemaker channel. The expression of this synthetic channel induced ectopic ventricular pacemaker activity upon focal injection.
50. Miller AG, Aldrich RW. Conversion of a delayed rectifier K+ channel to a voltage-gated inward rectifier K+ channel by three amino acid substitutions. Neuron 1996; 16:853-858.
51. Heginbotham L, Lu Z, Abramson T, MacKinnon R. Mutations in the K+ channel signature sequence. Biophys J 1994; 66:1061-1067.
52. Wang Z, Feng J, Shi H, et al. Potential molecular basis of different physiological properties of the transient outward K+ current in rabbit and human atrial myocytes. Circ Res 1999; 84:551-561.
53. Plotnikov AN, Shlapakova I, Szabolcs MJ, et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation 2007; 116:706-713.
54. Potapova I, Plotnikov A, Lu Z, et al. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res 2004; 94:952-959.
55. van der Velden HM, Jongsma HJ. Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets. Cardiovasc Res 2002; 54:270-279.
56. Cho HC, Kashiwakura Y, Marban E. Creation of a biological pacemaker by cell fusion. Circ Res 2007; 100:1112-1115. Syngeneic fibroblasts stably expressing HCN1 channels were fused to myocardium and the resulting heterokaryons developed spontaneously oscillating action potentials. The ECGs from such animals showed ectopic rhythms originating from the site of somatic cell fusion.
57. Shirahata S, Katakura Y, Teruya K. Cell hybridization, hybridomas, and human hybridomas. Methods Cell Biol 1998; 57:111-145.
58. Lentz BR, Lee JK. Poly(ethylene glycol) (PEG)-mediated fusion between pure lipid bilayers: a mechanism in common with viral fusion and secretory vesicle release? Mol Membr Biol 1999; 16:279-296.
59. Hoppe UC, Johns DC, Marban E, O'Rourke B. Manipulation of cellular excitability by cell fusion: effects of rapid introduction of transient outward K+ current on the guinea pig action potential. Circ Res 1999; 84:964-972.
60. Gibson AJ, Karasinski J, Relvas J, et al. Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle. J Cell Sci 1995; 108 (Pt 1):207-214.
61. Gussoni E, Bennett RR, Muskiewicz KR, et al. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 2002; 110:807-814.
62. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425:968-973.
63. Weimann JM, Johansson CB, Trejo A, Blau HM. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol 2003; 5:959-966.
64. Rosen AB, Kelly DJ, Schuldt AJ, et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007; 25:2128-2138. Quantum dot nanoparticles were used to track the fate of human mesenchymal stem cells upon injection intomammalian heart. After accounting for cell death and leakage of the nanoparticles, only about 30% of the injected cells still remain in the heart.
65. Cho HC, Kashiwakura Y, Marban E. Conversion of nonexcitable cells to self-contained biological pacemakers. Circulation 2005; 112:II-307.
66. Ren D, Navarro B, Xu H, et al. A prokaryotic voltage-gated sodium channel. Science 2001; 294:2372-2375.
67. Azene EM, Xue T, Marban E, et al. Nonequilibrium behavior of HCN channels: insights into the role of HCN channels in native and engineered pacemakers. Cardiovasc Res 2005; 67:263-273.